Stock data
Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT) reported revenue of US$1.86B and net income of -US$713.41M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.86B | — | -US$699.78M | -US$713.41M | — |
| 2024 | US$1.79B | — | US$218.08M | US$235.24M | — |
| 2023 | US$1.14B | — | -US$267.82M | -US$535.98M | — |
| 2022 | US$843.77M | — | -US$536.20M | -US$703.49M | — |
| 2021 | US$612.40M | — | -US$459.71M | -US$418.78M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$328.69M | -US$4.89M | — |
| 2026-03-31 | US$330.51M | US$330.96M | — |
| 2025-12-31 | US$369.61M | -US$282.85M | — |
| 2025-09-30 | US$370.04M | -US$179.95M | — |
| 2025-06-30 | US$513.12M | US$196.89M | — |
| 2025-03-31 | US$611.52M | -US$447.51M | — |
| 2024-12-31 | US$638.16M | US$159.05M | — |
| 2024-09-30 | US$429.77M | US$33.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.